SAN DIEGO, June 02, 2025 -- BioAtla, Inc. (Nasdaq: BCAB) (the “Company”), a global clinical-stage biotechnology company focused on the development of Conditionally Active Biologic (CAB) antibody therapeutics for the...
Scott Weiner will present and sit on a panel at the IN3 Medical Device 360 conference on February 29th through March 2nd in Orlando, Florida.
News | 02. 08. 2012
Scott Weiner will present and sit on a panel at the IN3 Medical Device 360 conference on February 29th through March 2nd in Orlando, Florida.
